Associate Director, International Market Access & Pricing - Oncology Pipeline

Benefits

Additional Information

The Associate Director, International Strategic Pricing, will be responsible for effectively manage pricing governance for on market assets, while ensuring for pipeline assets we translate the value of our assets and indications into both optimal pricing & contracting guidance, and where needed develop appropriate sustainable access model. They are responsible for working within the Value & Access Team for their Brands and or Indications to ensure we shape the price potential of our assets, through utilization of our strategic pricing framework and advanced modelling tools. They are also responsible for driving key scenario analysis such as Price Volume Time Tradeoffs and indication sequencing. Pricing plays a critical role within our integrated access strategies, and as such the Associate Directors for strategic pricing are core members of the Value & Access Teams. Working to shape our overall access strategies, payer value propositions, and other critical deliverables to affiliate access teams, across on-market and early to late-stage pipeline AbbVie assets. This role is also responsible for researching, evaluating, and identifying appropriate access models including Contracting Guidance, that would generate value for patients, healthcare systems and AbbVie. Given the importance of pricing to AbbVie's overall performance this role requires an ability to think strategically and creatively and requires strong matrix leadership and communication skills given the role demands regular engagement with key members of iMAP leadership team, and team members across the organization across including IMCO, PCS, R&D, Finance, and Commercial and Market access leadership from Affiliate through Region and Area to International HQ This role plays a key role in several of AbbVie's key financial processes from monthly S&OP meetings to annual Plan and Long-range planning cycles, responsible for accurate and timely tracking the price reimbursement and access performance and status of our strategic brands, development of plan and LRP price guidance for strategic and material brands within their therapy areas, alongside clear analytics, and causality for International price variances across the portfolio of assets within their therapy areas. Core Job Responsibilities: Anticipate and Shape External Environment: Evaluate & integrate new pricing approaches & Access models to optimize the value of our assets and drive broad and timely patient access in all markets 'segments, and support affiliates with identification of appropriate advocacy and policy objectives to support the implementation of these new access models. Ensure IAS includes appropriate disease level advocacy and policy objectives that if implemented may positively impact the price potential of EVEMA brands. Drive and Influence Strategies Internally, achieving Business Goals through: Strategic Pricing: Utilize the Strategic Pricing Framework to establish price potential of key brands and assets in their scope and advise value and access team on opportunities to improve /accelerate patient access across key International markets. Define pricing hypothesis, and conduct scenario analysis, identifying appropriate risk-mitigation strategies to be assessed, supporting the development of the integrated access strategy and pricing guidance, in collaboration with IMAP VAT lead, HTA lead, Area Market Access Therapy Area Leads, key markets/LBUs access teams, brand teams, Finance, DSG and other relevant key stakeholders. Inform and shape the integrated access strategy to ensure reflection of the asset price potential and implications, by proactively engaging and contributing through existing governed processes or decision forums (eg pipeline commercialization model/VAT) for a range of on market and pipeline assets. Develop short and long-term International pricing guidance over the asset lifecycle (e.g. early price range, late-stage price potential, pricing corridors & guidance), in line with the corporate strategy, brand vision, Integrated Access Strategy and asset value, in close collaboration with the iMAP VAT access lead, HTA lead and broader VAT. Create contracting guidance, to mitigate access risks and payer objections within the negotiation pathway, including evaluation of new access models. Ensuring that we assess the potential access models in the context of macroeconomic policy dynamics, healthcare system and infrastructure trends, pricing & reimbursement policy developments, innovative access models, and access stakeholder evolution. Contribute to the identification of asset access value drivers and drive incorporation of health care system dynamics including evaluation of traditional and innovative pricing & access models that enable achieving favorable reimbursement and address health care system affordability issues (e.g., payment models, funding mechanisms, innovation, alternative access programs/pathways. Develop asset indication sequence and/or country launch seq

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at Abbvie? Share your experience